Michelino D. Laurentiis
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal.
Journal: Cancer treatment reviews
Published: March 12, 2026
Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 23, 2025
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer.
Journal: Future oncology (London, England)
Published: June 30, 2023
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?
Journal: Future oncology (London, England)
Published: November 29, 2017
Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial).
Journal: ESMO open
Published: February 17, 2017
Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients.
Journal: American journal of translational research
Published: February 02, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026